{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:30:07Z","timestamp":1784367007588,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ebiom.2022.103856","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T23:12:05Z","timestamp":1644534725000},"page":"103856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b\/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-4333","authenticated-orcid":false,"given":"Tom M.","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-5503","authenticated-orcid":false,"given":"Erin E.","family":"Gaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annya","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-2855","authenticated-orcid":false,"given":"Oliver","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"MacKintosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Boz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Valanciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-9490","authenticated-orcid":false,"given":"Bethany","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Gwyer","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Jabbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-472X","authenticated-orcid":false,"given":"Andrew","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9ad","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Scholefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-3387","authenticated-orcid":false,"given":"Alastair F.","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islom B.","family":"Nazarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-1205","authenticated-orcid":false,"given":"James S.O.","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourosh H.","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Ferrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Rannard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Finlayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-2538","authenticated-orcid":false,"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Norrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-1682","authenticated-orcid":false,"given":"Ahsan R.","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-6655","authenticated-orcid":false,"given":"Daniel C.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Dear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.103856_bib0001","series-title":"Novel Coronavirus \u2013 China","year":"2020"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103856_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis","volume":"326","author":"Shankar-Hari","year":"2021","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.ebiom.2022.103856_bib0003","first-page":"693","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Group","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"10285","key":"10.1016\/j.ebiom.2022.103856_bib0004","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.ebiom.2022.103856_bib0005","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/AAC.01043-16","article-title":"Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay","volume":"60","author":"Yamamoto","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103856_bib0006","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/v12060629","article-title":"The anticoagulant nafamostat potently inhibits sars-cov-2 s protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner","volume":"12","author":"Yamamoto","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103856_bib0007","doi-asserted-by":"crossref","first-page":"e00754","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.ebiom.2022.103856_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00970-21","article-title":"The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19","author":"Li","year":"2021","journal-title":"mBio"},{"issue":"52","key":"10.1016\/j.ebiom.2022.103856_bib0009","doi-asserted-by":"crossref","first-page":"e2392","DOI":"10.1097\/MD.0000000000002392","article-title":"Nafamostat mesilate as an anticoagulant during continuous renal replacement therapy in patients with high bleeding risk: a randomized clinical trial","volume":"94","author":"Choi","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103856_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1527-3466.1995.tb00213.x","volume":"13","author":"Okajima","year":"1995","journal-title":"Cardiovascular Drug Reviews"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103856_bib0011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jjp.35.203","article-title":"Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments","volume":"35","author":"Aoyama","year":"1984","journal-title":"Jpn J Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103856_bib0012","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","article-title":"New synthetic inhibitors of C1r\u0304, C1 esterase, thrombin, plasmin, kallikrein and trypsin","volume":"661","author":"Fujii","year":"1981","journal-title":"Biochimica et Biophysica Acta (BBA) - Enzymology"},{"key":"10.1016\/j.ebiom.2022.103856_bib0013","article-title":"DEFINE: a phase iia randomised controlled trial to evaluate repurposed treatments for COVID-19","author":"Gaughan","year":"2021","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103856_bib0014","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: Technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"American Journal of Hematology"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103856_bib0015","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11239-020-02272-8","article-title":"Functional testing of tranexamic acid effects in patients undergoing elective orthopaedic surgery","volume":"51","author":"Groene","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103856_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000511230","article-title":"Functional testing for tranexamic acid duration of action using modified viscoelastometry","volume":"48","author":"Kammerer","year":"2021","journal-title":"Transfusion Medicine and Hemotherapy"},{"key":"10.1016\/j.ebiom.2022.103856_bib0017","series-title":"Generalized Linear Models","author":"McCullagh","year":"1983"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103856_bib0018","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/jmv.26397","article-title":"Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells","volume":"93","author":"Ko","year":"2021","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.ebiom.2022.103856_bib0019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijid.2020.05.072","article-title":"Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy","volume":"96","author":"Jang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103856_bib0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s13054-020-03078-z","article-title":"Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series","volume":"24","author":"Doi","year":"2020","journal-title":"Critical Care"},{"key":"10.1016\/j.ebiom.2022.103856_bib0021","unstructured":"EUnetHTA Joint Action 3 WP4: NAFAMOSTAT FOR THE TREATMENT OF COVID-19. Version 7.0, May 2021"},{"issue":"8","key":"10.1016\/j.ebiom.2022.103856_bib0022","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/0306-3623(95)00072-0","article-title":"Mechanisms of hyperkalemia caused by nafamostat mesilate","volume":"26","author":"Muto","year":"1995","journal-title":"Gen Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103856_bib0023","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00216-008-2054-4","article-title":"A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study","volume":"391","author":"Cao","year":"2008","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103856_bib0024","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2133\/dmpk.21.147","article-title":"Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis","volume":"21","author":"Yamaori","year":"2006","journal-title":"Drug Metabolism and Pharmacokinetics"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103856_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389200219666180821094502","article-title":"The impact of carboxylesterases in drug metabolism and pharmacokinetics","volume":"20","author":"Di","year":"2019","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.ebiom.2022.103856_bib0026","unstructured":"group TLdi. COVID-19 Drug interactions, 2021 [accessed 5\/8\/21.2021]."},{"issue":"6","key":"10.1016\/j.ebiom.2022.103856_bib0027","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103856_bib0028","first-page":"559","article-title":"The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes","volume":"13","author":"Malato","year":"2015","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103856_bib0029","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103856_bib0030","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103856_bib0031","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/CCM.0000000000004471","article-title":"Thromboelastography profiles of critically Ill patients with coronavirus disease 2019","volume":"48","author":"Yuriditsky","year":"2020","journal-title":"Crit Care Med"},{"issue":"6508","key":"10.1016\/j.ebiom.2022.103856_bib0032","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"issue":"49","key":"10.1016\/j.ebiom.2022.103856_bib0033","doi-asserted-by":"crossref","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Science Immunology"},{"key":"10.1016\/j.ebiom.2022.103856_bib0034","article-title":"Evaluation of nafamostat mesylate safety and inhibition of SARS-CoV-2 replication using a 3-dimensional human airway epithelia model","author":"Kirkpatrick","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ebiom.2022.103856_bib0035","article-title":"SARS-CoV-2 Spreads through cell-to-cell transmission","author":"Zeng","year":"2021","journal-title":"bioRxiv"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:17:11Z","timestamp":1762456631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":35,"alternative-id":["S2352396422000408"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103856","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.06.21264648","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b\/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103856"}}